header logo image header logo text
Downloads Login
Research
General Information
ZIRC
ZFIN ID: ZDB-FISH-150901-2160
Fish name: jh1Tg
Genotype: jh1Tg
Targeting Reagent: none
HUMAN DISEASE MODELED by jh1Tg
No data available
GENE EXPRESSION
Gene expression in jh1Tg
RNA expression
Expressed Gene Structure Conditions Figures
anxa4 standard conditions Fig. 4 with image from Zhang et al., 2014
cabp1b standard conditions Fig. 2 with image from Di Donato et al., 2013
gcga control Fig. S2 with image from Won et al., 2015
ins standard conditions Fig. 4 with image from Dash et al., 2016
Fig. 7 with imageFig. 8 with image from Mastracci et al., 2015
Fig. S2 with imageFig. S5 with image from Won et al., 2015
Fig. 1 with image from Poulain et al., 2011
chemical treatment by environment: 2-(7-aminoheptyl)guanidine Fig. 8 with image from Mastracci et al., 2015
klf8 standard conditions Fig. S6 with image from Tsai et al., 2015
nkx6.1 standard conditions Fig. 2 with image from Zhang et al., 2017
Fig. 2Fig. S2 from Dong et al., 2008
numb control Fig. 7 with imageFig. S5 with image from Won et al., 2015
pdx1 standard conditions Fig. 2 with image from Zhang et al., 2017
Fig. 5 with image from Dash et al., 2016
Fig. 2 with image from Mastracci et al., 2015
chemical treatment by environment: eflornithine Fig. 2 with image from Mastracci et al., 2015
prox1a standard conditions Fig. 2 with image from Shin et al., 2012
prss1 control Fig. 1 with image from Mastracci et al., 2015
chemical treatment by environment: eflornithine Fig. 1 with image from Mastracci et al., 2015
ptf1a control Fig. 4 with image from Jusuf et al., 2009
rbpms2b control Fig. 5 with image from Jusuf et al., 2009
sox2 control Fig. 5 with image from Jusuf et al., 2009
tcf7l1a standard conditions Fig. 2 with image from Facchinello et al., 2017
tcf7l1b standard conditions Fig. 2 with image from Facchinello et al., 2017
tcf7l2 standard conditions Fig. 2 with image from Facchinello et al., 2017
Protein expression
Antibody Antigen Genes Structure Conditions Figures
Ab-5E11 control Fig. 5 with image from Jusuf et al., 2009
Ab2-isl standard conditions Fig. 2 with imageFig. 3 with image from Zhang et al., 2017
Fig. 4 with image from Xu et al., 2016
Fig. 3Fig. 4Fig. S3 from Dong et al., 2008
Ab2-prkcb control Fig. 5 with image from Jusuf et al., 2009
Ab-2F11 standard conditions Fig. 4 with image from Zhang et al., 2014
Fig. 3 with imageFig. 4 with image from Matsuda et al., 2013
Fig. 2 with image from Shin et al., 2012
Ab4-krt18 standard conditions Fig. 3 with image from Bielczyk-Maczyńska et al., 2015
Ab1-GABA control Fig. 5 with image from Jusuf et al., 2009
Ab1-tuba standard conditions Fig. 2 with image from Uribe et al., 2016
Ab1-pvalb control Fig. 5 with image from Jusuf et al., 2009
Ab1-elavl standard conditions Fig. 1 with image from Uribe et al., 2016
Ab4-tjp1 standard conditions Fig. 4 with image from Zhang et al., 2017
Ab2-cpa1 standard conditions Fig. 3 with image from Bielczyk-Maczyńska et al., 2015
Ab8-prox1 control Fig. 5 with image from Jusuf et al., 2009
Ab-SV2 standard conditions Fig. 2 with image from Lancman et al., 2013
Ab2-ins standard conditions Fig. 2 with image from Lancman et al., 2013
Fig. 3 from Dong et al., 2008
Ab1-pan-Cadherin standard conditions Fig. 2 with imageFig. 3 with image from Zhang et al., 2017
Fig. 2Fig. 3Fig. 4Fig. S3 from Dong et al., 2008
Ab3-calb2 control Fig. 5 with image from Jusuf et al., 2009
Ab1-glul control Fig. 5 with image from Jusuf et al., 2009
Ab1-ins ins control Fig. 4 with image from Dash et al., 2016
Ab2-nkx6 nkx6.1 standard conditions Fig. 2 with image from Zhang et al., 2017
Ab3-prox1 prox1a standard conditions Fig. 2 with image from Shin et al., 2012
Fig. 1 with imageFig. 3 with image from Poulain et al., 2011
Fig. 2Fig. S2 from Dong et al., 2008
Ab1-rbpms2 rbpms2b control Fig. 5 with image from Jusuf et al., 2009
Ab1-sox2 sox2 control Fig. 5 with image from Jusuf et al., 2009
PHENOTYPE
Phenotype in jh1Tg
Phenotype Conditions Figures
endocrine pancreas ins expression decreased amount, abnormal chemical treatment by environment: 2-(7-aminoheptyl)guanidine Fig. 8 with image from Mastracci et al., 2015
endocrine pancreas development disrupted, abnormal chemical treatment by environment: 2-(7-aminoheptyl)guanidine Fig. 8 with image from Mastracci et al., 2015
exocrine pancreas EGFP expression decreased distribution, abnormal chemical treatment by environment: eflornithine Fig. 3 with image from Mastracci et al., 2015
exocrine pancreas EGFP expression decreased distribution, abnormal control Fig. 4 with image from Xu et al., 2016
exocrine pancreas decreased length, abnormal chemical treatment by environment: eflornithine Fig. 1 with imageFig. 3 with image from Mastracci et al., 2015
exocrine pancreas decreased length, abnormal chemical treatment by environment: 2-(7-aminoheptyl)guanidine Fig. 8 with image from Mastracci et al., 2015
exocrine pancreas exocrine cell decreased amount, abnormal control Fig. 4 with image from Xu et al., 2016
exocrine pancreas pancreas induction decreased occurrence, abnormal control Fig. 4 with image from Xu et al., 2016
exocrine pancreas development disrupted, abnormal chemical treatment by environment: eflornithine Fig. 1 with imageFig. 3 with image from Mastracci et al., 2015
exocrine pancreas development disrupted, abnormal chemical treatment by environment: 2-(7-aminoheptyl)guanidine Fig. 8 with image from Mastracci et al., 2015
extrahepatic duct present, normal standard conditions Fig. 2 with image from Shin et al., 2012
extrapancreatic duct morphology, normal standard conditions Fig. 2 with image from Shin et al., 2012
hindbrain EGFP expression decreased amount, abnormal chemical treatment by environment: eflornithine Fig. 1 with image from Mastracci et al., 2015
islet growth decreased process quality, abnormal chemical treatment by environment: perfluorooctane-1-sulfonic acid Fig. 4 from Sant et al., 2017
liver present, normal standard conditions Fig. 2 with image from Shin et al., 2012
liver development increased occurrence, abnormal control Fig. 4 with image from Xu et al., 2016
pancreas EGFP expression decreased amount, abnormal chemical treatment by environment: eflornithine Fig. 1 with image from Mastracci et al., 2015
pancreas EGFP expression decreased amount, abnormal chemical treatment by environment: 2-(7-aminoheptyl)guanidine Fig. 8 with image from Mastracci et al., 2015
pancreas prss1 expression decreased amount, abnormal chemical treatment by environment: eflornithine Fig. 1 with image from Mastracci et al., 2015
pancreas size, normal chemical treatment by environment: eflornithine Fig. 1 with image from Mastracci et al., 2015
pancreatic bud pdx1 expression decreased amount, abnormal chemical treatment by environment: eflornithine Fig. 2 with image from Mastracci et al., 2015
pancreatic bud numb expression increased distribution, abnormal control Fig. 7 with image from Won et al., 2015
primary islet has fewer parts of type pancreatic B cell, abnormal chemical treatment by environment: 2-(7-aminoheptyl)guanidine Fig. 8 with image from Mastracci et al., 2015

CITATIONS  (57)